Probing the ligand-induced conformational change in HLA-DR1 by selective chemical modification and mass spectrometric mapping

被引:39
作者
Carven, GJ
Stern, LJ
机构
[1] Univ Massachusetts, Sch Med, Dept Pathol, Worcester, MA 01655 USA
[2] MIT, Dept Chem, Cambridge, MA 02139 USA
关键词
D O I
10.1021/bi050972p
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Peptide binding induces conformational changes in class 11 MHC proteins that have been characterized using a variety of hydrodynamic and spectroscopic approaches, but these changes have not been clearly localized within the overall class 11 MHC structure. In this study, empty and peptide-loaded complexes of HLA-DR1, a common class 11 MHC variant, were chemically modified using the side chain-specific chemical modifiers p-hydroxyphenylglyoxal (arginine), tetranitromethane (tyrosine), N-bromosuccinimide (tryptpophan), and NHS-biotin (lysine). Modified proteins were subjected to in-gel digestion with trypsin and subsequent analysis by MALDI/MS. Three arginine residues and two lysine residues were differentially reactive, modified in the empty form but not the peptide-loaded form of the protein, indicating that the chemical reactivity of these regions differs in the two conformations. Three of the differential modifications were located on a single lateral face of the protein, indicating that this region is involved in the conformational change. Additionally, a number of lysine and tyrosine modification sites were present in both protein conformations. Overall, the pattern of reactivity is inconsistent with the idea that empty MHC molecules exist as molten globules or other partially unfolded intermediates, and suggests that the peptide-induced conformational change is localized to only a few regions of the protein.
引用
收藏
页码:13625 / 13637
页数:13
相关论文
共 58 条
[1]  
Anthony-Cahill Spencer J., 2002, Current Pharmaceutical Biotechnology, V3, P299
[2]  
Beck AP, 2001, TEX J SCI, V53, P353
[3]   Early biochemical signals arise from low affinity TCR-ligand reactions at the cell-cell interface [J].
Beeson, C ;
Rabinowitz, J ;
Tate, K ;
Gutgemann, I ;
Chien, YH ;
Jones, PP ;
Davis, MM ;
McConnell, HM .
JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 184 (02) :777-782
[4]   KINETIC INTERMEDIATES IN THE REACTIONS BETWEEN PEPTIDES AND PROTEINS OF MAJOR HISTOCOMPATIBILITY COMPLEX CLASS-II [J].
BEESON, C ;
MCCONNELL, HM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (19) :8842-8845
[5]   Evidence for a conformational change in a class II major histocompatibility complex molecule occurring in the same pH range where antigen binding is enhanced [J].
Boniface, JJ ;
Lyons, DS ;
Wettstein, DA ;
Allbritton, NL ;
Davis, MM .
JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 183 (01) :119-126
[6]   Structural characterization of a soluble and partially folded class I major histocompatibility heavy chain/β2m heterodimer [J].
Bouvier, M ;
Wiley, DC .
NATURE STRUCTURAL BIOLOGY, 1998, 5 (05) :377-384
[7]   A HYPOTHETICAL MODEL OF THE FOREIGN ANTIGEN-BINDING SITE OF CLASS-II HISTOCOMPATIBILITY MOLECULES [J].
BROWN, JH ;
JARDETZKY, T ;
SAPER, MA ;
SAMRAOUI, B ;
BJORKMAN, PJ ;
WILEY, DC .
NATURE, 1988, 332 (6167) :845-850
[8]   SELECTIVE CHEMICAL CLEAVAGE OF TRYPTOPHANYL PEPTIDE BONDS IN PEPTIDES AND PROTEINS [J].
BURSTEIN, Y ;
PATCHORNIK, A .
BIOCHEMISTRY, 1972, 11 (25) :4641-+
[9]   Monoclonal antibodies specific for the empty conformation of HLA-DR1 reveal aspects of the conformational change associated with peptide binding [J].
Carven, GJ ;
Chitta, S ;
Hilgert, I ;
Rushe, MM ;
Baggio, RF ;
Palmer, M ;
Arenas, JE ;
Strominger, JL ;
Horejsi, V ;
Santambrogio, L ;
Stern, LJ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (16) :16561-16570
[10]   HLA-DM recognizes the flexible conformation of major histocompatibility complex class II [J].
Chou, CL ;
Sadegh-Nasseri, S .
JOURNAL OF EXPERIMENTAL MEDICINE, 2000, 192 (12) :1697-1706